Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
biosyn Arzneimittel GmbH is a family-owned pharmaceutical and biotech company based in Germany, specializing in trace elements, world-class biologics, and specialized oncology treatments. The company is a global leader in the production of high-purity sodium selenite for medical use and is a primary manufacturer of Keyhole Limpet Hemocyanin (KLH), a potent immunomodulator used in bladder cancer therapy and as a carrier protein for vaccines. With a focus on intensive care, oncology, and endocrinology, biosyn provides both proprietary pharmaceutical products and active pharmaceutical ingredients (APIs) to the global market. The company maintains a strong presence in over 25 countries through a network of partners and subsidiaries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosyn Genetics.